PHATNasdaq United States
Market cap
$691.703 M
$8.55 +1.91%
Close of 7 Aug 2026
Revenue
$175.1M
#2345 by revenue
Earnings
-$221.3K
Loss-making
Shares outstanding
80,900,934
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Phathom Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.